John Brandsema, MD
Areas of expertise: Nerve conduction studies, Neuromuscular/MDA clinic, Pediatric electromyography
Locations: Main Building, Buerger Center for Advanced Pediatric Care
About John Brandsema, MD
John Brandsema, MD, is a pediatric neurologist in the Division of Neurology at Children’s Hospital of Philadelphia (CHOP). He has a special interest in treating children with neuromuscular disorders and is enthusiastic about the promise that medical and scientific advances hold for people with these conditions.
“Genetic breakthroughs are increasing accuracy of diagnosis while novel targeted therapeutics are changing lives,” Dr. Brandsema says.
Dr. Brandsema is involved with clinical trials of novel therapeutics for neuromuscular disorders.
His philosophy of care centers around developing strong partnerships with families and empowering parents to understand their child’s medical condition.
“I want them to know that we will work together to achieve the best possible quality of life for their loved one,” Dr. Brandsema says.
Children benefit from a team approach to care that includes not just their family and neurologist, but professionals across medical specialties, he says. Dr. Brandsema expects this model of care will continue to evolve as collaborative research leads to a greater understanding of rare neurological disorders.
Titles
Attending Physician
Certifications
Pediatric Neurology – Royal College of Physicians and Surgeons of Canada
Research Interests
Clinical trials for neuromuscular diseases
Education & training
Medical Degree
MD - Dalhousie University, Halifax, Nova Scotia, Canada
Residency
Pediatric Neurology - The Hospital for Sick Children, Toronto, Canada
Fellowship
Neuromuscular Medicine - Harvard Medical School, Massachusetts General Hospital, Boston, MA
Publications
Publications
2019
Kim AG, Upah SA, Brandsema JF, Yum SW, Blinman TA. Thoracoscopic thymectomy for juvenile myasthenia gravis. Pediatr Surg Int. 2019 May;35(5):603-610. doi: 10.1007/s00383-019-04441-0. Epub 2019 Feb 7.
2018
Burgart AM, Magnus D, Tabor HK, Paquette ED, Frader J, Glover JJ, Jackson BM, Harrison CH, Urion DK, Graham RJ, Brandsema JF, Feudtner C. Ethical Challenges Confronted When Providing Nusinersen Treatment for Spinal Muscular Atrophy. JAMA Pediatrics. 2018 Feb 1;172(2):188-192.
2017
Tiao J, Feng R, Berger EM, Brandsema JF, Coughlin CC, Khan N, Kichula EA, Lerman MA, Lvovich S, McMahon PJ, Rider LG, Rubin AI, Scalzi LV, Smith DM, Taxter AJ, Treat JR, Williams RP, Yum SW, Okawa J, Werth VP. Evaluation of the reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index and the Cutaneous Assessment Tool-Binary Method in juvenile dermatomyositis among paediatric dermatologists, rheumatologists and neurologists. Br Jr Dermatology. 2017 Oct;177(4):1086-1092.
2015
Brandsema JF, Darras BT. Dystrophinopathies. Seminars in Neurology. 2015 Aug;35(4):369-84.
2010
Brandsema JF, Stephens D, Hartley J, Yoon G. Intermediate-dose idebenone and quality of life in Friedreich ataxia. Pediatr Neurol. 2010 May;42(5):338-42.
2009
Rea D, Brandsema JF, Armstrong D, Parkin PC, Deveber G, Macgregor D, Logan WJ, Askalan R. Cerebral arteriopathy in children with neurofibromatosis type 1. Pediatrics. 2009 Sep;124(3):e476-83. Epub 2009 Aug 24.
2001
Pogue BW, Pitts JD, Mycek MA, Sloboda RD, Wilmot CM, Brandsema JF, O'Hara JA. In vivo NADH fluorescence monitoring as an assay for cellular damage in photodynamic therapy. Photochem Photobiol. 2001 Dec;74(6):817-24.